Results 1 to 10 of about 259 (175)
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations [PDF]
This is Part 2 of an updated follow-up review of the World Allergy Organization (WAO) position paper on the diagnosis and treatment of urticaria and angioedema.
Mario Sánchez-Borges +10 more
doaj +5 more sources
Key differences between chronic inducible and spontaneous urticaria
IntroductionThe latest international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for urticaria recommends limited laboratory testing for chronic spontaneous urticaria (CSU) and selective testing for only certain chronic inducible urticaria (CIndU ...
Mojca Bizjak +3 more
doaj +6 more sources
Prevalence of Chronic Inducible Urticaria in Elderly Patients [PDF]
Background: No data currently exist regarding the epidemiology of chronic inducible urticarias (CIndUs) in the ≥65-year-old population. Objective: The study aimed to determine the prevalence of CIndUs among elderly patients affected by chronic urticaria (CU).
Luca Stingeni, , Maddalena Napolitano
exaly +6 more sources
Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both [PDF]
Chronic urticaria (CU) is a common skin disorder, which can be further divided into chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). Omalizumab is effective and safe for difficult-to-treat CSU based on clinical trials. However, there are limited data comparing the therapeutic effect of omalizumab for patients with CSU, CIndU,
Marcus Maurer, Xiaojie Huang, Ping Tu
exaly +6 more sources
Chronic spontaneous urticaria and chronic inducible urticaria
Chronic urticaria is defined by pruritic wheals with or without angioedema, associated with severe itch, which persist for greater than 6 weeks. Chronic urticaria can be divided into chronic spontaneous urticaria and chronic inducible urticaria. Chronic spontaneous urticaria has no identifiable trigger, whereas chronic inducible urticaria can be ...
Jonathan Bernstein
exaly +3 more sources
Omalizumab in the Treatment of Chronic Inducible Urticaria
Omalizumab is a recombinant humanized monoclonal antibody that inhibits immunoglobulin E. It has been approved for the treatment of severe asthma and chronic spontaneous urticaria refractory to other treatments. Its use in the management of chronic inducible urticaria (a type triggered by certain stimuli) is still considered off-label, although this ...
Pablo Chicharro Manso, Diego De Argila
exaly +3 more sources
Challenges in Differentiating Chronic Inducible Urticaria from Chronic Spontaneous Urticaria
Ethan Bendayan,1 Alexandre Ton That,1 Catherine Keying Zhu,2 Elena Netchiporouk,2,3,* Moshe Ben-Shoshan4,* 1Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada; 2Division of Dermatology, Department of Medicine,
Bendayan E +4 more
doaj +3 more sources
Chronic inducible urticaria: treatment algorithm
Chronic inducible urticaria (CindU) is a prevalent skin disease characterized by the appearance of recurrent wheals, angioedema or both, as a response to specific and reproducible triggers.
D. M. Skander +2 more
doaj +1 more source
IgE receptor responsiveness of basophils in chronic inducible urticaria
Introduction Chronic inducible urticaria (CIndU) is a subgroup of chronic urticaria induced by a specific stimulus. We evaluated basophil characteristics in patients with CIndU and compared with those in patients with chronic spontaneous urticaria (CSU) and healthy controls (HCs).
Shinya Imamura +2 more
exaly +4 more sources
Background: The urticaria control test (UCT) is a questionnaire designed to determine if chronic urticaria (CU) is controlled or not and to aid therapeutic decision-making.
Emek Kocatürk +9 more
doaj +3 more sources

